Despite countless efforts been made for development of drugs that inhibit the interaction of p53 with Mdm2 or Mdmx in cancers, the role of Mdmx after cerebral ischemia and its possibility as a therapeutic drug have not yet been reported. This evidence concerns the gene TP53 and cancer.